Extent of Surgery in Thyroglossal Duct Carcinoma

Reflections on a Series of Eighteen Cases

Paolo Miccoli, Michele N. Minuto, David Galleri, Marco Puccini, Piero Berti

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

The occurrence of carcinoma of the thyroglossal duct remnant (TDRCa) is reported to be less than 1%. We retrospectively analyzed 18 cases (14 females, 4 males; mean age, 38.17 years) of TDRCa who underwent surgery in our department, to evaluate the correct workup for diagnosis and treatment. Nine patients underwent a total thyroidectomy and a Sistrunk procedure (SP) whereas 8 underwent a completion total thyroidectomy after a postoperative diagnosis of TDRCa. One patient was diagnosed with TDRCa several years after total thyroidectomy for goiter. Postoperatively all patients were given radioiodide and levothyroxine therapy. Mean follow-up was 85 months. No patient died of tumor-related disease. Thyroglossal duct neoplasms were represented by papillary carcinoma in 16 cases; thyroid histology demonstrated papillary carcinoma in 6 cases (33.3%). Three patients demonstrated single regional node metastasis and only one of them demonstrated the presence of malignant thyroid disease. When clinical diagnosis of thyroglossal duct cyst is made, the workup should be completed by ultrasound (US) scan and fine-needle aspiration cytology (FNAC) in order to plan the correct surgery for a possible TDRCa. Total thyroidectomy should always be considered with SP to permit the correct treatment and follow-up in those patients. Long-term survival of patients with TDRCa is excellent.

Original languageEnglish
Pages (from-to)121-123
Number of pages3
JournalThyroid
Volume14
Issue number2
DOIs
Publication statusPublished - Feb 2004

Fingerprint

Carcinoma
Thyroidectomy
Papillary Carcinoma
Thyroglossal Cyst
Thyroid Diseases
Goiter
Fine Needle Biopsy
Thyroxine
Cell Biology
Neoplasms
Histology
Thyroid Gland
Therapeutics
Neoplasm Metastasis
Survival

ASJC Scopus subject areas

  • Endocrinology

Cite this

Miccoli, P., Minuto, M. N., Galleri, D., Puccini, M., & Berti, P. (2004). Extent of Surgery in Thyroglossal Duct Carcinoma: Reflections on a Series of Eighteen Cases. Thyroid, 14(2), 121-123. https://doi.org/10.1089/105072504322880355

Extent of Surgery in Thyroglossal Duct Carcinoma : Reflections on a Series of Eighteen Cases. / Miccoli, Paolo; Minuto, Michele N.; Galleri, David; Puccini, Marco; Berti, Piero.

In: Thyroid, Vol. 14, No. 2, 02.2004, p. 121-123.

Research output: Contribution to journalArticle

Miccoli, P, Minuto, MN, Galleri, D, Puccini, M & Berti, P 2004, 'Extent of Surgery in Thyroglossal Duct Carcinoma: Reflections on a Series of Eighteen Cases', Thyroid, vol. 14, no. 2, pp. 121-123. https://doi.org/10.1089/105072504322880355
Miccoli, Paolo ; Minuto, Michele N. ; Galleri, David ; Puccini, Marco ; Berti, Piero. / Extent of Surgery in Thyroglossal Duct Carcinoma : Reflections on a Series of Eighteen Cases. In: Thyroid. 2004 ; Vol. 14, No. 2. pp. 121-123.
@article{98ecc89b3f3340108410f2a73706c8a0,
title = "Extent of Surgery in Thyroglossal Duct Carcinoma: Reflections on a Series of Eighteen Cases",
abstract = "The occurrence of carcinoma of the thyroglossal duct remnant (TDRCa) is reported to be less than 1{\%}. We retrospectively analyzed 18 cases (14 females, 4 males; mean age, 38.17 years) of TDRCa who underwent surgery in our department, to evaluate the correct workup for diagnosis and treatment. Nine patients underwent a total thyroidectomy and a Sistrunk procedure (SP) whereas 8 underwent a completion total thyroidectomy after a postoperative diagnosis of TDRCa. One patient was diagnosed with TDRCa several years after total thyroidectomy for goiter. Postoperatively all patients were given radioiodide and levothyroxine therapy. Mean follow-up was 85 months. No patient died of tumor-related disease. Thyroglossal duct neoplasms were represented by papillary carcinoma in 16 cases; thyroid histology demonstrated papillary carcinoma in 6 cases (33.3{\%}). Three patients demonstrated single regional node metastasis and only one of them demonstrated the presence of malignant thyroid disease. When clinical diagnosis of thyroglossal duct cyst is made, the workup should be completed by ultrasound (US) scan and fine-needle aspiration cytology (FNAC) in order to plan the correct surgery for a possible TDRCa. Total thyroidectomy should always be considered with SP to permit the correct treatment and follow-up in those patients. Long-term survival of patients with TDRCa is excellent.",
author = "Paolo Miccoli and Minuto, {Michele N.} and David Galleri and Marco Puccini and Piero Berti",
year = "2004",
month = "2",
doi = "10.1089/105072504322880355",
language = "English",
volume = "14",
pages = "121--123",
journal = "Thyroid",
issn = "1050-7256",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Extent of Surgery in Thyroglossal Duct Carcinoma

T2 - Reflections on a Series of Eighteen Cases

AU - Miccoli, Paolo

AU - Minuto, Michele N.

AU - Galleri, David

AU - Puccini, Marco

AU - Berti, Piero

PY - 2004/2

Y1 - 2004/2

N2 - The occurrence of carcinoma of the thyroglossal duct remnant (TDRCa) is reported to be less than 1%. We retrospectively analyzed 18 cases (14 females, 4 males; mean age, 38.17 years) of TDRCa who underwent surgery in our department, to evaluate the correct workup for diagnosis and treatment. Nine patients underwent a total thyroidectomy and a Sistrunk procedure (SP) whereas 8 underwent a completion total thyroidectomy after a postoperative diagnosis of TDRCa. One patient was diagnosed with TDRCa several years after total thyroidectomy for goiter. Postoperatively all patients were given radioiodide and levothyroxine therapy. Mean follow-up was 85 months. No patient died of tumor-related disease. Thyroglossal duct neoplasms were represented by papillary carcinoma in 16 cases; thyroid histology demonstrated papillary carcinoma in 6 cases (33.3%). Three patients demonstrated single regional node metastasis and only one of them demonstrated the presence of malignant thyroid disease. When clinical diagnosis of thyroglossal duct cyst is made, the workup should be completed by ultrasound (US) scan and fine-needle aspiration cytology (FNAC) in order to plan the correct surgery for a possible TDRCa. Total thyroidectomy should always be considered with SP to permit the correct treatment and follow-up in those patients. Long-term survival of patients with TDRCa is excellent.

AB - The occurrence of carcinoma of the thyroglossal duct remnant (TDRCa) is reported to be less than 1%. We retrospectively analyzed 18 cases (14 females, 4 males; mean age, 38.17 years) of TDRCa who underwent surgery in our department, to evaluate the correct workup for diagnosis and treatment. Nine patients underwent a total thyroidectomy and a Sistrunk procedure (SP) whereas 8 underwent a completion total thyroidectomy after a postoperative diagnosis of TDRCa. One patient was diagnosed with TDRCa several years after total thyroidectomy for goiter. Postoperatively all patients were given radioiodide and levothyroxine therapy. Mean follow-up was 85 months. No patient died of tumor-related disease. Thyroglossal duct neoplasms were represented by papillary carcinoma in 16 cases; thyroid histology demonstrated papillary carcinoma in 6 cases (33.3%). Three patients demonstrated single regional node metastasis and only one of them demonstrated the presence of malignant thyroid disease. When clinical diagnosis of thyroglossal duct cyst is made, the workup should be completed by ultrasound (US) scan and fine-needle aspiration cytology (FNAC) in order to plan the correct surgery for a possible TDRCa. Total thyroidectomy should always be considered with SP to permit the correct treatment and follow-up in those patients. Long-term survival of patients with TDRCa is excellent.

UR - http://www.scopus.com/inward/record.url?scp=1642316363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642316363&partnerID=8YFLogxK

U2 - 10.1089/105072504322880355

DO - 10.1089/105072504322880355

M3 - Article

VL - 14

SP - 121

EP - 123

JO - Thyroid

JF - Thyroid

SN - 1050-7256

IS - 2

ER -